The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603479.pdf
Reference49 articles.
1. Bashirullah A, Cooperstock RL, Lipshitz HD (2001) Spatial and temporal control of RNA stability. Proc Natl Acad Sci USA 98: 7025–7028
2. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH (1998) p14ARF links the tumour suppressors RB and p53. Nature 395: 124–125
3. Boltze C, Zack S, Quednow C, Bettge S, Roessner A, Schneider-Stock R (2003) Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis. Pathol Res Pract 199: 399–404
4. Calabro V, Strazzullo M, La Mantia G, Fedele M, Paulin C, Fusco A, Lania L (1996) Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines. Int J Cancer 67: 29–34
5. Capella G, Matias-Guiu X, Ampudia X, de Leiva A, Perucho M, Prat J (1996) Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis form paraffin-embedded tissues. Diagn Mol Pathol 5: 45–52
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma;BMC Medical Genomics;2024-05-22
2. Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer;Molecular Oncology;2024-03-08
3. Comprehensive analysis of cellular senescence and immune microenvironment in papillary thyroid carcinoma;Aging;2024-02-07
4. Molecular Diagnostics and [18F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources?;Thyroid®;2024-01-01
5. Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches;Life Sciences;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3